Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases

NCT03368625 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03368625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03368625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
March 19, 2018
Completion date
October 10, 2025
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases